Literature DB >> 19696488

Articulatory agility in cognitive decline.

Per Ostberg1, Nenad Bogdanović, Lars-Olof Wahlund.   

Abstract

OBJECTIVE: Motor speech disorders are believed to be uncommon in early Alzheimer's disease (AD). However, data from maximum performance tests of motor speech function in AD and related disorders are virtually nonexistent. The aim of this study was to make such data available.
MATERIALS AND METHODS: Sequential speech motion rate was analyzed in 236 memory clinic patients with different levels of cognitive functioning.
RESULTS: Sequential speech motion rate was moderately but significantly decreased in mild dementia in AD. About 10% of AD and mild cognitive impairment cases had markedly decreased rates. Rates were strongly reduced in progressive nonfluent aphasia, whereas semantic dementia did not differ from subjective cognitive impairment. Frontotemporal dementia had lower rates than AD.
CONCLUSIONS: A proportion of patients with cognitive decline has markedly reduced articulatory agility. The cause of this reduction in some patients with mild cognitive impairment and mild AD is unknown. Semantic dementia is not associated with impaired articulatory agility.

Entities:  

Mesh:

Year:  2009        PMID: 19696488     DOI: 10.1159/000235649

Source DB:  PubMed          Journal:  Folia Phoniatr Logop        ISSN: 1021-7762            Impact factor:   0.849


  3 in total

1.  Presence redefined: The reciprocal nature of engagement between elder-clowns and persons with dementia.

Authors:  Pia Kontos; Karen-Lee Miller; Gail Joyce Mitchell; Jan Stirling-Twist
Journal:  Dementia (London)       Date:  2016-07-27

2.  Communication Difficulty and Relevant Interventions in Mild Cognitive Impairment: Implications for Neuroplasticity.

Authors:  Melissa Johnson; Feng Lin
Journal:  Top Geriatr Rehabil       Date:  2014-01

3.  Automatic Detection of Cognitive Impairments through Acoustic Analysis of Speech.

Authors:  Ryosuke Nagumo; Yaming Zhang; Yuki Ogawa; Mitsuharu Hosokawa; Kengo Abe; Takaaki Ukeda; Sadayuki Sumi; Satoshi Kurita; Sho Nakakubo; Sangyoon Lee; Takehiko Doi; Hiroyuki Shimada
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.